OBJECTIVES: To examine associations between specific inflammatory biomarkers and cognitive function in African Americans (AAs) and European Americans (EAs) with prevalent vascular risk factors. DESIGN: Cross-sectional analysis using generalized estimating equations to account for familial clustering; standardized β-coefficients, adjusted for age, sex, and education are reported. SETTING: Community cohort study in Jackson, Mississippi, and Rochester, Minnesota. PARTICIPANTS: Genetic Epidemiology Network of Arteriopathy (GENOA)-Genetics of Microangiopathic Brain Injury (GMBI) Study participants. MEASUREMENTS: Associations between inflammation (high-sensitivity C-reactive protein (CRP), interleukin (IL)-6, soluble tumor necrosis factor (TNF) receptor 1 and 2 (sTNFR1, sTNFR2)) and cognitive function (global, processing speed, language, memory, and executive function) were examined in AAs and EAs (N = 1,965; aged 26-95, 64% women, 52% AA, 75% with hypertension). RESULTS: In AAs, higher sTNFR2 was associated with poorer cognition in all domains (global: -0.11, P = .009; processing speed: -0.11, P < .001; language: -0.08, P = .002; memory: -0.09, P = .008; executive function: -0.07, P = .03); sTNFR1 was associated with slower processing speed (-0.08, P < .001) and poorer executive function (-0.08, P = .008); higher CRP was associated with slower processing speed (-0.04, P = .024), and higher IL6 was associated with poorer executive function (-0.07, P = .02). In EA, only higher sTNFR1 was associated with slower processing speed (-0.05, P = .007). Associations were not found between cognition and sTNFR2, CRP, or IL6 in EA. CONCLUSION: In a population with high vascular risk, adverse associations between inflammation and cognitive function were especially apparent in AAs, primarily involving markers of TNFα activity.
OBJECTIVES: To examine associations between specific inflammatory biomarkers and cognitive function in African Americans (AAs) and European Americans (EAs) with prevalent vascular risk factors. DESIGN: Cross-sectional analysis using generalized estimating equations to account for familial clustering; standardized β-coefficients, adjusted for age, sex, and education are reported. SETTING: Community cohort study in Jackson, Mississippi, and Rochester, Minnesota. PARTICIPANTS: Genetic Epidemiology Network of Arteriopathy (GENOA)-Genetics of Microangiopathic Brain Injury (GMBI) Study participants. MEASUREMENTS: Associations between inflammation (high-sensitivity C-reactive protein (CRP), interleukin (IL)-6, soluble tumor necrosis factor (TNF) receptor 1 and 2 (sTNFR1, sTNFR2)) and cognitive function (global, processing speed, language, memory, and executive function) were examined in AAs and EAs (N = 1,965; aged 26-95, 64% women, 52% AA, 75% with hypertension). RESULTS: In AAs, higher sTNFR2 was associated with poorer cognition in all domains (global: -0.11, P = .009; processing speed: -0.11, P < .001; language: -0.08, P = .002; memory: -0.09, P = .008; executive function: -0.07, P = .03); sTNFR1 was associated with slower processing speed (-0.08, P < .001) and poorer executive function (-0.08, P = .008); higher CRP was associated with slower processing speed (-0.04, P = .024), and higher IL6 was associated with poorer executive function (-0.07, P = .02). In EA, only higher sTNFR1 was associated with slower processing speed (-0.05, P = .007). Associations were not found between cognition and sTNFR2, CRP, or IL6 in EA. CONCLUSION: In a population with high vascular risk, adverse associations between inflammation and cognitive function were especially apparent in AAs, primarily involving markers of TNFα activity.
Authors: Angela L Jefferson; Joseph M Massaro; Alexa S Beiser; Sudha Seshadri; Martin G Larson; Philip A Wolf; Rhoda Au; Emelia J Benjamin Journal: Neuroepidemiology Date: 2011-07-13 Impact factor: 3.282
Authors: Riccardo E Marioni; Marlene C Stewart; Gordon D Murray; Ian J Deary; F Gerry R Fowkes; Gordon D O Lowe; Ann Rumley; Jackie F Price Journal: Psychosom Med Date: 2009-08-06 Impact factor: 4.312
Authors: Nancy S Jenny; Benjamin French; Alice M Arnold; Elsa S Strotmeyer; Mary Cushman; Paulo H M Chaves; Jingzhong Ding; Linda P Fried; Stephen B Kritchevsky; Dena E Rifkin; Mark J Sarnak; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2012-02-24 Impact factor: 6.053
Authors: Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler Journal: N Engl J Med Date: 2003-03-27 Impact factor: 91.245
Authors: Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett Journal: Psychol Aging Date: 2002-06
Authors: Vesna Jordanova; Robert Stewart; Emma Davies; Roy Sherwood; Martin Prince Journal: Int J Geriatr Psychiatry Date: 2007-10 Impact factor: 3.485
Authors: Kirby G Parker; Seth T Lirette; David S Deardorff; Lawrence F Bielak; Patricia A Peyser; J Jeffrey Carr; James G Terry; Myriam Fornage; Emelia J Benjamin; Stephen T Turner; Thomas H Mosley; Michael E Griswold; B Gwen Windham Journal: J Gerontol A Biol Sci Med Sci Date: 2018-03-14 Impact factor: 6.053
Authors: Daniel R van Langenberg; Greg W Yelland; Stephen R Robinson; Peter R Gibson Journal: United European Gastroenterol J Date: 2016-08-08 Impact factor: 4.623
Authors: Mike F Schmidt; Kevin B Freeman; Beverly G Windham; Michael E Griswold; Iftikhar J Kullo; Stephen T Turner; Thomas H Mosley Journal: J Am Geriatr Soc Date: 2016-08-22 Impact factor: 5.562
Authors: B Gwen Windham; Seth T Lirette; Myriam Fornage; Emelia J Benjamin; Kirby G Parker; Stephen T Turner; Clifford R Jack; Michael E Griswold; Thomas H Mosley Journal: J Gerontol A Biol Sci Med Sci Date: 2017-06-01 Impact factor: 6.053
Authors: Elizabeth A Boots; Liang Zhan; Karla J Castellanos; Lisa L Barnes; Lisa Tussing-Humphreys; Melissa Lamar Journal: Brain Imaging Behav Date: 2021-07-16 Impact factor: 3.978